β-1,3-glucan from Euglena gracilis : a promising epidrug targeting epigenetic regulators PRMTs and SIRTs for therapeutic applications in ovarian cancer.

Autor: Palol VV; Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India., Waidha K; The Shraga Segal Department of Microbiology, Immunology & Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel., Moovarkumudalvan B; Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India., Valavath Baburajan N; National Institute of Advanced Studies, IISc. Campus, Bangalore, India., Saravanan SK; Mahatma Gandhi Medical Preclinical Research Centre (MGMPRC), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India., Lakshmanan D; Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India., Subramanyam V; Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India., Chinnadurai RK; Mahatma Gandhi Medical Advanced Research Institute (MGMARI), Sri Balaji Vidyapeeth (Deemed-to-be University), Pillayarkuppam, Puducherry, India.

Publikováno v: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2024 Nov 13, pp. 1-16. Date of Electronic Publication: 2024 Nov 13.